GenScript ProBio vs ProBio

GenScript ProBio logo

GenScript ProBio

A comprehensive R&D and production platform offering complete solutions for cell and gene therapy, vaccine discovery, and antibody protein drugs

1001-5000 employees · est. 2002

VS
ProBio logo

ProBio

Manufacturing Life-Changing Therapies

246 employees · est. 2020 · United States

GenScript ProBio is the older company (2002 vs 2020); GenScript ProBio is the larger of the two.

Side-by-Side Comparison

GenScript ProBio ProBio
Founded
2002 older 2020
Headquarters
Not tracked yet United States
Employees
1001-5000 larger 246
Industry
Biopharma, Pharmaceutical Biopharma, Biotechnology, Life Sciences
Funding Stage
Series C Series C
Total Funding
$220.00M Not tracked yet
Funding Rounds
1 Not tracked yet
Services
Not tracked yet End-to-End CDMO Services, Biologics Drug Discovery, Plasmid and Viral Vector Solutions, Clinical and Commercial Manufacturing, Therapeutic Antibody Services, Process Optimization and Validation
Target Customers
Not tracked yet Biopharma Companies, Global Biotech Innovators, Research and Development Teams, Clinical Trial Sponsors
Taxonomy
Biopharmaceutical R&DCell And Gene TherapyVaccine DiscoveryAntibody Protein DrugsCDMOAdvanced Therapies +5 Contract Development And Manufacturing OrganizationBiopharmaceutical R&DAdvanced TherapiesBiologics DevelopmentProtein-based TherapeuticsMRNA Vaccine Manufacturing +9
Website
genscriptprobio.cn probiocdmo.com
GenScript ProBio logo

About GenScript ProBio

GenScript ProBio, a leading biopharmaceutical R&D and production platform, offers comprehensive solutions for cell and gene therapy, vaccine discovery, and antibody protein drugs. Established in 2002, the company has made significant strides in the Biopharma and Pharmaceutical industries. In its lat...

ProBio logo

About ProBio

ProBio, founded in 2020, and headquartered in the United States, is a global contract development and manufacturing organization (CDMO) poised at the forefront of the biopharmaceutical industry. With its slogan, "Manufacturing Life-Changing Therapies," ProBio focuses on accelerating the production o...

Also comparing in this category

Comparing more than these two?

Get GenScript ProBio, ProBio and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does GenScript ProBio compare?

A PDF of GenScript ProBio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Frequently Asked Questions

GenScript ProBio was founded in 2002, with 1001-5000 employees. GenScript ProBio, a leading biopharmaceutical R&D and production platform, offers comprehensive solutions for cell and gene therapy, vaccine discovery, and antibody protein drugs. Established in 2002,. ProBio was founded in 2020, based in United States, with 246 employees. ProBio, founded in 2020, and headquartered in the United States, is a global contract development and manufacturing organization (CDMO) poised at the forefront of the biopharmaceutical industry. With.
GenScript ProBio has raised $220.00M and ProBio no disclosed funding. Latest stage: GenScript ProBio Series C, ProBio Series C.
Both work in Biopharma and Pharmaceutical and list biopharmaceutical r&d, advanced therapies and biologics development among their focus areas.

Compare GenScript ProBio with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at GenScript ProBio on 12 Sep 2024, and ProBio on 4 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes